ArticleEuropean journal of breast health2026
Endoscopic and Robotic Minimally Invasive Breast Surgery (MIBS) for Benign Breast Lesions: Our Experience of 80 Cases and Descriptive Comparison.
Article in European journal of breast health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Minimally invasive breast surgery (MIBS) via an extramammary approach offers an alternative to conventional open lumpectomy, eliminating breast scarring and improving psychological outcomes in patients with benign breast lesions. While endoscopic MIBS (EMIBS) has been described, data on robotic MIBS (RMIBS) are sparse. We analyzed the clinical and cosmetic outcomes of EMIBS and RMIBS. Materials and Methods: Eighty patients undergoing MIBS for benign breast lumps were divided into endoscopic ( Results: Groups were comparable in age ( Conclusion: We demonstrate the feasibility and safety of both approaches for benign breast lesions, with comparable and favorable cosmetic outcomes, and with the robotic platform offering subjective improvement in ergonomic strain, especially in difficult-to-access medial quadrants. These findings are hypothesis-generating and require validation using instruments such as NASA-TLX or the Borg CR-10 scale in larger studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.